14 results
DEF 14A
SYRA
Syra Health Corp - Ordinary Shares
24 Apr 24
Definitive proxy
5:01pm
.
CORPORATE GOVERNANCE STANDARDS AND DIRECTOR INDEPENDENCE
We are committed to good corporate governance practices. These practices provide an important … with respect to the management of corporate, legal and regulatory risk.
Director Independence
Our Class A common stock is listed on the Nasdaq Capital Market
10-K
2023 FY
SYRA
Syra Health Corp - Ordinary Shares
25 Mar 24
Annual report
3:01pm
, AND DIRECTOR INDEPENDENCE
The information required by this item is incorporated by reference from the information contained in the 2024 Proxy Statement
8-K
EX-3.1
SYRA
Syra Health Corp - Ordinary Shares
4 Oct 23
Syra Health Corp. Announces Pricing of Upsized Initial Public Offering
4:45pm
understanding of the independence or lack of independence of such proposed nominee.
(iv) For purposes of this Section 2.5, the term “Nominating Person” shall … ownership and independence of such proposed nominee and (b) a written representation and agreement (in form provided by the Corporation) that such proposed
424B4
SYRA
Syra Health Corp - Ordinary Shares
3 Oct 23
Prospectus supplement with pricing info
6:10am
officers or directors.
Director Independence
Prior to the consummation of this offering, our board of directors undertook a review of the independence … ” under the Nasdaq rules, and that they meet the independence standards under Rule 10A-3. Each member of our audit committee meets the financial literacy
S-1/A
dawi3r13il cp2
12 Jun 23
IPO registration (amended)
9:05pm
S-1
EX-3.4
xxrndmj92xdh3x
3 May 23
IPO registration
9:34pm
S-1
kevsea6lv hl7f4v
3 May 23
IPO registration
9:34pm
S-1
EX-3.3
stm 9jvgrrs
3 May 23
IPO registration
9:34pm
- Prev
- 1
- Next